Mallory Smallze
Nurse Practitioner · Fair Lawn, NJNPI 1053045203
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,113 of the $2,409 with a category attached, or 87.7%. It is spread thinly across 31 manufacturers, the largest accounting for just 12.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,438 and has fallen 73.3% since, to $384 in 2024. Among nurse practitioner clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 109 payments — averaging $22.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$297
- Merck$218
- Amgen$186
- Novartis$171
- Seagen Inc.$163
- E.r. Squibb & Sons, L.L.C.$148
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,11388%
- Education$29612%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 12 | $297 |
| Merck | 13 | $218 |
| Amgen(2 entities) | 4 | $186 |
| Novartis | 9 | $171 |
| Seagen Inc. | 6 | $163 |
| E.r. Squibb & Sons, L.L.C. | 5 | $148 |
| Eisai Inc. | 8 | $131 |
| Medtronic | 3 | $117 |
| AbbVie | 2 | $112 |
| Bayer | 5 | $110 |
| Emmaus Medical, Inc. | 5 | $99 |
| Exelixis Inc. | 1 | $99 |
| Johnson & Johnson | 6 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Bristol Myers Squibb | 3 | $48 |
| Daiichi Sankyo Inc. | 3 | $47 |
| EMD Serono, Inc. | 3 | $45 |
| Sanofi | 3 | $38 |
| Pfizer | 2 | $33 |
| Macrogenics, Inc. | 2 | $31 |
| Genentech USA, Inc. | 1 | $20 |
| Sobi, Inc | 1 | $18 |
| Ardelyx, Inc. | 1 | $17 |
| Redhill Biopharma Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $16 |
| Incyte Corporation | 1 | $15 |
| Rigel Pharmaceuticals, Inc. | 1 | $14 |
| Global Blood Therapeutics, Inc. | 1 | $14 |
| Blueprint Medicines Corporation | 1 | $14 |
| Astellas Pharma US Inc | 1 | $14 |
| Alnylam Pharmaceuticals Inc. | 1 | $13 |
How this compares
$2,409 in reported general payments places this provider in the 90th percentile of 2,138 nurse practitioner providers in New Jersey.
Other nurse practitioner in Fair Lawn
- Nancy BonnetMorristown$407K
- Vanessa CoppolaCloster$205K
- Olufunmilayo IloriUnion$133K
- Janice BeitzHaddon Heights$75K
- Adewale AdefowojuUnion$70K
- Sophia KimEnglewood$70K
- Elizabeth FletcherCamden$62K
- Lannae EwingLinwood$39K
- Beth SavageNew Brunswick$34K
- Tina OcchiutoMorristown$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.